Harnessing Computational Strategies to Overcome Challenges in mRNA Vaccines
Physiology · 2025
DOI: 10.1152/physiol.00047.2024 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Physiology, 2025. Verfasst von Siyu Zhao und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: RNA, Messenger, COVID-19 Vaccines, COVID-19, mRNA Vaccines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 101 Literaturangaben. Gefördert von: the National Key Research and Development Program of China, the Fund of Wenzhou Institute University of Chinese Academy of Sciences,Key Research and Development Grant of MOST, the Fund of Wenzhou Institute University of Chinese Academy of Science,Key Reaearch and Development Grant of NSFC.
Abstract (Originalsprache)
In recent years, the introduction of mRNA vaccines for SARS-CoV2 and respiratory syncytial virus (RSV) has highlighted the success of the mRNA technology platform. Designing mRNA sequences involves multiple components and requires balancing several parameters, including enhancing transcriptional efficiency, boosting antigenicity, and minimizing immunogenicity. Moreover, changes in the composition and properties of delivery vehicles can also affect vaccine performance. Traditional methods of experimentally testing these conditions are time-consuming, labor-intensive, and costly, necessitating advanced optimization strategies. Recently, the rapid development of computational tools has significantly accelerated the optimization process for mRNA vaccines. In this review, we systematically examine computation-aided approaches for optimizing mRNA components, including coding and noncoding regions, and for improving the efficiency of lipid nanoparticle (LNP) delivery systems by focusing on their composition, ratios, and characterization. The use of computational tools can significantly accelerate mRNA vaccine development, enabling rapid responses to emerging infectious diseases and supporting the development of precise, personalized therapies. These approaches may guide the future direction of mRNA vaccine development. Our review aims to provide integrated constructive support for computer-aided mRNA vaccine design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Critical Care Medicine, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
- Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, China.
- Centre for Translational Research in Cancer, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
ORCID-Profile: Hu Zhang, Shugang Qin, Xiangrong Song
Förderung
- the National Key Research and Development Program of China
- the Fund of Wenzhou Institute University of Chinese Academy of Sciences,Key Research and Development Grant of MOST
- the Fund of Wenzhou Institute University of Chinese Academy of Science,Key Reaearch and Development Grant of NSFC
Zitieren
APA
Zhao, S., Chen, J., Dai, T., Li, G., Huang, L., Xin, J., Zhang, Y., Chen, Y., He, X., Huang, H., Yin, X., Liu, S., Guo, M., Zhang, H., Qin, S., Wu, M., & Song, X. (2025). Harnessing Computational Strategies to Overcome Challenges in mRNA Vaccines. Physiology. https://doi.org/10.1152/physiol.00047.2024
Vancouver
Zhao S, Chen J, Dai T, Li G, Huang L, Xin J, et al. Harnessing Computational Strategies to Overcome Challenges in mRNA Vaccines. Physiology. 2025. doi:10.1152/physiol.00047.2024
BibTeX
@article{Zhao2025,
author = {Zhao, Siyu and Chen, Jingjing and Dai, Tian and Li, Guohong and Huang, Letao and Xin, Jinxiu and Zhang, Yupei and Chen, Yuting and He, Xi and Huang, Hai and Yin, Xiaoling and Liu, Shengbin and Guo, Mengran and Zhang, Hu and Qin, Shugang and Wu, Min and Song, Xiangrong},
title = {Harnessing Computational Strategies to Overcome Challenges in mRNA Vaccines},
journal = {Physiology},
year = {2025},
doi = {10.1152/physiol.00047.2024}
}
EUVIMED